Cabozantinib product-specific bioequivalence guidance

This document provides product-specific guidance on the demonstration of the bioequivalence of cabozantinib tablet 20 mg, 40 mg and 60 mg.

Keywords: Bioequivalence, generics, cabozantinib


  • BCS Classification: Biopharmaceutics Classification System
  • AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
  • Cmax: maximum plasma concentration


How useful was this page?

Add your rating